# NYSTATIN

NDC: 69315-504
Generic name: NYSTATIN
Labeler / Manufacturer: Leading Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20221205

FDA application: ANDA214346

## Active ingredients

- NYSTATIN: 100000 [USP'U]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69315-504"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69315-504
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=954205d8-47ba-4c89-95cd-f0066a514cf9